Expression of connexin 43 in the human epileptic and drug-resistant cerebral cortex

Neurology

Volumn 76, Issue 10, 2011, Pages 895-902

  Garbelli, R ^a   Frassoni, C ^a   Condorelli, D F ^b   Trovato Salinaro, A ^b   Musso, N ^b   Medici, V ^a   Tassi, L ^c   Bentivoglio, M ^d   Spreafico, R ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 43; MESSENGER RNA;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; ASTROCYTE; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INTRACTABLE EPILEPSY; MALE; NEUROPATHOLOGY; NEUROSURGERY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

EID: 79952978219     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31820f2da6     Document Type: Article

References (38)

1. Nemani VM, Binder DK. Emerging role of gap junctions in epilepsy. Histol Histopathol 2005;20:253-259. (Pubitemid 40029003)
2. Giaume C, Fromaget C, el Aoumari A, Cordier J, Glowin-ski J, Gros D. Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron 1991;6:133-143.
3. Charles A. Intercellular calcium waves in glia. Glia 1998; 24:39-49. (Pubitemid 28370211)
4. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4:285-294. (Pubitemid 36383955)
5. Naus CC, Bechberger JF, Paul DL. Gap junction gene expression in human seizure disorder. Exp Neurol 1991; 111:198-203.
6. Elisevich K, Rempel SA, Smith BJ, Edvardsen K. Hip-pocampal connexin 43 expression in human complex partial seizure disorder. Exp Neurol 1997;145:154-164. (Pubitemid 27244289)
7. Aronica E, Gorter JA, Jansen GH, Leenstra S, Yankaya B, Troost D. Expression of connexin 43 and connexin 32 gap-junction proteins in epilepsy-associated brain tumors and in the perilesional epileptic cortex. Acta Neuropathol 2001;101:449-459. (Pubitemid 32600134)
8. Fonseca CG, Green CR, Nicholson LF. Upregulation in astrocytic connexin 43 gap junction levels may exacerbate generalized seizures in mesial temporal lobe epilepsy. Brain Res 2002;929:105-116. (Pubitemid 34164415)
9. Collignon F, Wetjen NM, Cohen-Gadol AA, et al. Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans. J Neurosurg 2006;105:77-87. (Pubitemid 43979101)
10. Gigout S, Louvel J, Kawasaki H, et al. Effects of gap junction blockers on human neocortical synchronization. Neu-robiol Dis 2006;22:496-508. (Pubitemid 43832123)
11. Lerner JT, Salamon N, Hauptman JS, et al. Assessment and surgical outcomes for mild type I and severe type II cortical dysplasia: a critical review and the UCLA experience. Epilepsia 2009;50:1310-1335.
12. Palmini A, Najm I, Avanzini G, et al. Terminology and classification of the cortical dysplasias. Neurology 2004; 62:S2-S8. (Pubitemid 38419835)
13. Garbelli R, Munari C, De Biasi S, et al. Taylor's cortical dysplasia: a confocal and ultrastructural immunohisto-chemical study. Brain Pathol 1999;9:445-461. (Pubitemid 29316285)
14. Mullen RJ, Buck CR, Smith AM. NeuN, a neuronal specific nuclear protein in vertebrates. Development 1992; 116:201-211.
15. Alonso-Nanclares L, Garbelli R, Sola RG, et al. Micro-anatomy of the dysplastic neocortex from epileptic patients. Brain 2005;128:158-173. (Pubitemid 40070530)
16. Goldstein ME, Sternberger LA, Sternberger NH. Micro-heterogeneity ("neurotypy") of neurofilament proteins. Proc Natl Acad Sci USA 1983;80:3101-3105.
17. Debus E, Weber K, Osborn M. Monoclonal antibodies specific for glial fibrillary acidic (GFA) protein and for each of the neurofilament triplet polypeptides. Differentiation 1983;25:193-203. (Pubitemid 14219914)
18. Osborn M, Debus E, Weber K. Monoclonal antibodies specific for vimentin. Eur J Cell Biol 1984;34:137-143. (Pubitemid 14056649)
19. Urbach H, Scheffler B, Heinrichsmeier T, et al. Focal cortical dysplasia of Taylor's balloon cell type: a clinicopatho-logical entity with characteristic neuroimaging and histopathological features, and favorable postsurgical outcome. Epilepsia 2002;43:33-40. (Pubitemid 34215450)
20. De Sousa PA, Valdimarsson G, Nicholson BJ, Kidder GM. Connexin trafficking and the control of gap junction assembly in mouse preimplantation embryos. Development 1993;117:1355-1367. (Pubitemid 23154500)
21. Krause DS, Fackler MJ, Civin CI, May WS. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13. (Pubitemid 26018389)
22. Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C. Glioblastoma multiforme with long term survival. Neurol India 2005;53:329-332. (Pubitemid 41526848)
23. Sisodiya SM, Fauser S, Cross JH, Thom M. Focal cortical dysplasia type II: biological features and clinical perspectives. Lancet Neurol 2009;8:830-843.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159. (Pubitemid 17064313)
25. Belluardo N, Trovato-Salinaro A, Mudo G, Condorelli DF. Expression of the rat connexin 39 (rCx39) gene in myoblasts and myotubes in developing and regenerating skeletal muscles: an in situ hybridization study. Cell Tissue Res 2005;320:299-310. (Pubitemid 40684756)
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
27. Fauser S, Becker A, Schulze-Bonhage A, et al. CD34-immunoreactive balloon cells in cortical malformations. Acta Neuropathol 2004;108:272-278. (Pubitemid 39317694)
28. Najm I, Ying Z, Babb T, et al. Mechanisms of epileptoge-nicity in cortical dysplasias. Neurology 2004;62:S9-S13.
29. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain 2002;125:1719-1732.
30. Crino PB, Miyata H, Vinters HV. Neurodevelopmental disorders as a cause of seizures: neuropathologic, genetic, and mechanistic considerations. Brain Pathol 2002;12: 212-233. (Pubitemid 34259924)
31. Hildebrandt M, Pieper T, Winkler P, Kolodziejczyk D, Holthausen H, Blumcke I. Neuropathological spectrum of cortical dysplasia in children with severe focal epilepsies. Acta Neuropathol 2005;110:1-11. (Pubitemid 41131191)
32. Kettenmann H. Physiology of glial cells. Adv Neurol 1999;79:565-571.
33. Zhou M, Kimelberg HK. Freshly isolated astrocytes from rat hippocampus show two distinct current patterns and different [K(+)] (o) uptake capabilities. J Neurophysiol 2000;84:2746-2757.
34. Cepeda C, Hurst RS, Flores-Hernandez J, et al. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia. J Neurosci Res 2003;72:472-486. (Pubitemid 36523422)
35. Theis M, Sohl G, Eiberger J, Willecke K. Emerging complexities in identity and function of glial connexins. Trends Neurosci 2005;28:188-195. (Pubitemid 40445525)
36. Xu L, Zeng LH, Wong M. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2009;34: 291-299.
37. Carlen PL, Skinner F, Zhang L, Naus C, Kushnir M, Perez Velazquez JL. The role of gap junctions in seizures. Brain Res Brain Res Rev 2000;32:235-241. (Pubitemid 30177328)
38. Medina-Ceja L, Cordero-Romero A, Morales-Villagran A. Antiepileptic effect of carbenoxolone on seizures induced by 4-aminopyridine: a study in the rat hippocampus and entorhinal cortex. Brain Res 2008;1187:74-81. (Pubitemid 350191812)